Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise

Jump to navigation Jump to search

Chronic stable angina Microchapters

Acute Coronary Syndrome Main Page

Home

Patient Information

Overview

Historical Perspective

Classification

Classic
Chronic Stable Angina
Atypical
Walk through Angina
Mixed Angina
Nocturnal Angina
Postprandial Angina
Cardiac Syndrome X
Vasospastic Angina

Differentiating Chronic Stable Angina from Acute Coronary Syndromes

Pathophysiology

Epidemiology and Demographics

Risk Stratification

Pretest Probability of CAD in a Patient with Angina

Prognosis

Diagnosis

History and Symptoms

Physical Examination

Test Selection Guideline for the Individual Basis

Laboratory Findings

Electrocardiogram

Exercise ECG

Chest X Ray

Myocardial Perfusion Scintigraphy with Pharmacologic Stress

Myocardial Perfusion Scintigraphy with Thallium

Echocardiography

Exercise Echocardiography

Computed coronary tomography angiography(CCTA)

Positron Emission Tomography

Ambulatory ST Segment Monitoring

Electron Beam Tomography

Cardiac Magnetic Resonance Imaging

Coronary Angiography

Treatment

Medical Therapy

Revascularization

PCI
CABG
Hybrid Coronary Revascularization

Alternative Therapies for Refractory Angina

Transmyocardial Revascularization (TMR)
Spinal Cord Stimulation (SCS)
Enhanced External Counter Pulsation (EECP)
ACC/AHA Guidelines for Alternative Therapies in patients with Refractory Angina

Discharge Care

Patient Follow-Up
Rehabilitation

Secondary Prevention

Guidelines for Asymptomatic Patients

Noninvasive Testing in Asymptomatic Patients
Risk Stratification by Coronary Angiography
Pharmacotherapy to Prevent MI and Death in Asymptomatic Patients

Landmark Trials

Case Studies

Case #1

Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise

CDC onChronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise

Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise in the news

Blogs on Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise

to Hospitals Treating Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise

Risk calculators and risk factors for Chronic stable angina risk stratification cardiac stress imaging in patients who are able to exercise

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S.

Overview

Cardiac stress imaging consisting of echocardiography and myocardial perfusion scan, which are assessed both at rest and during stress, provide a useful way to stratify the risk of underlying coronary artery disease (CAD) and hence aid in the management of chronic stable angina. Cardiac stress imaging in a patient who is able to exercise is indicated in the presence of resting ECG abnormalities or in patients who are on digoxin. A normal post-stress thallium scan indicates a low probability of underlying CAD, however, a normal image in a patient with high-risk treadmill scores requires further evaluation.[1]

Stress Echocardiography

  • During stress, the extent and severity of abnormal contractile response is expressed as wall motion score index (WMSI).[3]
Contractile response Peak WMSI Cardiac event rate
Normal response 1.0 0.9% per year
Mild-to-moderate contractile dysfunction 1.1–1.7 3.1% per year
Severe contractile dysfunction greater than 1.7 5.2% per year

Myocardial Perfusion Imaging

  • Scintigraphic features suggestive of adverse cardiac events include:[8]
  • Cavity dilatation,
  • Low ejection fraction,
  • End-systolic and end-diastolic volumes,
  • Post-stress myocardial stunning.

ACC / AHA Guidelines- Cardiac Stress Imaging for Risk Stratification of Patients With Chronic Stable Angina Who Are Able to Exercise (DO NOT EDIT)[9]

Class I
"1. Exercise myocardial perfusion imaging or exercise echocardiography to identify the extent, severity, and location of ischemia in patients who do not have left bundle-branch block or an electronically paced ventricular rhythm and have either an abnormal rest ECG or are using digoxin. (Level of Evidence: B)"
"2. Dipyridamole or adenosine myocardial perfusion imaging in patients with left bundle-branch block or electronically paced ventricular rhythm. (Level of Evidence: B)"
"3. Exercise myocardial perfusion imaging or exercise echocardiography to assess the functional significance of coronary lesions (if not already known) in planning PTCA. (Level of Evidence: B)"
Class III
"1. Exercise myocardial perfusion imaging in patients with left bundle-branch block. (Level of Evidence: C)"
"2. Exercise, dipyridamole, adenosine myocardial perfusion imaging, or exercise or dobutamine echocardiography in patients with severe comorbidity likely to limit life expectation or prevent revascularization. (Level of Evidence: C)"
Class IIb
"1. Exercise or dobutamine echocardiography in patients with left bundle-branch block. (Level of Evidence: C)"
"2. Exercise, dipyridamole, adenosine myocardial perfusion imaging, or exercise or dobutamine echocardiography as the initial test in patients who have a normal rest ECG and are not taking digoxin. (Level of Evidence: B)"

ESC Guidelines- Risk Stratification according to Exercise Stress ECG in patients Who Can Exercise (DO NOT EDIT)[10]

Class I
"1. All patients without significant resting ECG abnormalities undergoing initial evaluation. (Level of Evidence: B)"
"2. Patients with stable coronary artery disease after a significant change in symptom level. (Level of Evidence: C)"
Class IIa
"1. Patients post-revascularization with a significant deterioration in symptomatic status. (Level of Evidence: B)"

ESC Guidelines- Risk Stratification according to Exercise Stress Imaging (Perfusion or Echocardiography) in patients Who Can Exercise (DO NOT EDIT)[10]

Class I
"1. Patients with resting ECG abnormalities, LBBB, more than 1 mm ST depression, paced rhythm, or Wolff Parkinson White syndrome which prevent accurate interpretation of ECG changes during stress. (Level of Evidence: C)

"

"2. Patients with a non-conclusive exercise ECG, but intermediate or high probability of disease. (Level of Evidence: B)"
Class IIa
"1. In patients with a deterioration in symptoms post-revascularization. (Level of Evidence: B)"
"2. As an alternative to exercise ECG in patients where facilities, cost, and personnel resources allow. (Level of Evidence: B)"

References

  1. 1.0 1.1 Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA et al. (1998) Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (6):535-43. PMID: 9494023
  2. Chaudhry FA (1996) The role of stress echocardiography versus stress perfusion: a view from the other side. J Nucl Cardiol 3 (6 Pt 2):S66-74. PMID: 8989689
  3. Yao SS, Qureshi E, Sherrid MV, Chaudhry FA (2003) Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol 42 (6):1084-90. PMID: 13678935
  4. Beller GA, Zaret BL (2000) Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 101 (12):1465-78. PMID: 10736294
  5. Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman JD, Shaw LJ (2002) Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 105 (7):823-9. PMID: 11854122
  6. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS (2004) Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol 43 (2):200-8. PMID: 14736438
  7. 7.0 7.1 Poornima IG, Miller TD, Christian TF, Hodge DO, Bailey KR, Gibbons RJ (2004) Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol 43 (2):194-9. PMID: 14736437
  8. Beller GA, Watson DD (2004) Risk stratification using stress myocardial perfusion imaging: don't neglect the value of clinical variables. J Am Coll Cardiol 43 (2):209-12. PMID: 14736439
  9. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM et al. (1999) ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 99 (21):2829-48. [1] PMID: 10351980
  10. 10.0 10.1 Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F; et al. (2006). "Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology". Eur Heart J. 27 (11): 1341–81. doi:10.1093/eurheartj/ehl001. PMID 16735367.

Template:WikiDoc Sources